Philippe Pouletty, M.D., is Chairman of the board at Abivax. He is also Managing Partner of Truffle Capital. He is a pioneer in the biotechnology and medical devices sector. As an entrepreneur, he founded/co-founded among others: Carmat, Deinove, Pharnext, Vexim — Truffle portfolio companies. As an inventor, Dr. Pouletty has filed 32 patents, one of which is the second-highest revenue generator in life sciences for Stanford University, earning him membership in Stanford’s Invention Hall of Fame in 2012. Dr. Pouletty was Chairman of France Biotech from 2001 to 2009 and has held the title of Honorary Chairman since 2009.
Interview with the CEO and the Chairman: Abivax (OTCMKTS:AAVXF)
September 22, 2020